ha 1004 has been researched along with Adenocarcinoma, Basal Cell in 1 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " Normal human endometrial stromal cells and RL95-2 human endometrial adenocarcinoma cells were treated for 1 h with TAM, a known antagonist of protein kinase C (PKC), or with staurosporine or HA1004, two broad-spectrum protein kinase antagonists capable of inhibiting PKC and PKA, respectively." | 3.69 | Tamoxifen alters the localization of F-actin and alpha 5/beta 1-integrin fibronectin receptors in human endometrial stromal cells and carcinoma cells. ( Albright, CD; Carter, CA; Kaufman, DG, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albright, CD | 1 |
| Carter, CA | 1 |
| Kaufman, DG | 1 |
1 other study available for ha 1004 and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Tamoxifen alters the localization of F-actin and alpha 5/beta 1-integrin fibronectin receptors in human endometrial stromal cells and carcinoma cells.
Topics: Actins; Adenocarcinoma; Cells, Cultured; Endometrial Neoplasms; Enzyme Inhibitors; Female; Fluoresce | 1997 |